Global Ankylosing Spondylitis Treatment Drug Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Ankylosing Spondylitis Treatment Drug Market Size 2017-2028

2.1.2 Ankylosing Spondylitis Treatment Drug Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Ankylosing Spondylitis Treatment Drug Segment by Type

2.2.1 Non-steroidal Anti-inflammatory Drugs

2.2.2 Inhibitor

2.3 Ankylosing Spondylitis Treatment Drug Market Size by Type

2.3.1 Ankylosing Spondylitis Treatment Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Ankylosing Spondylitis Treatment Drug Market Size Market Share by Type (2017-2022)

2.4 Ankylosing Spondylitis Treatment Drug Segment by Application

2.4.1 Hospital Pharmacy

2.4.2 Retail Pharmacy

2.4.3 Online Pharmacy

2.4.4 Other

2.5 Ankylosing Spondylitis Treatment Drug Market Size by Application

2.5.1 Ankylosing Spondylitis Treatment Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Ankylosing Spondylitis Treatment Drug Market Size Market Share by Application (2017-2022)

3 Ankylosing Spondylitis Treatment Drug Market Size by Player

3.1 Ankylosing Spondylitis Treatment Drug Market Size Market Share by Players

3.1.1 Global Ankylosing Spondylitis Treatment Drug Revenue by Players (2020-2022)

3.1.2 Global Ankylosing Spondylitis Treatment Drug Revenue Market Share by Players (2020-2022)

3.2 Global Ankylosing Spondylitis Treatment Drug Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Ankylosing Spondylitis Treatment Drug by Regions

4.1 Ankylosing Spondylitis Treatment Drug Market Size by Regions (2017-2022)

4.2 Americas Ankylosing Spondylitis Treatment Drug Market Size Growth (2017-2022)

4.3 APAC Ankylosing Spondylitis Treatment Drug Market Size Growth (2017-2022)

4.4 Europe Ankylosing Spondylitis Treatment Drug Market Size Growth (2017-2022)

4.5 Middle East & Africa Ankylosing Spondylitis Treatment Drug Market Size Growth (2017-2022)

5 Americas

5.1 Americas Ankylosing Spondylitis Treatment Drug Market Size by Country (2017-2022)

5.2 Americas Ankylosing Spondylitis Treatment Drug Market Size by Type (2017-2022)

5.3 Americas Ankylosing Spondylitis Treatment Drug Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Ankylosing Spondylitis Treatment Drug Market Size by Region (2017-2022)

6.2 APAC Ankylosing Spondylitis Treatment Drug Market Size by Type (2017-2022)

6.3 APAC Ankylosing Spondylitis Treatment Drug Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Ankylosing Spondylitis Treatment Drug by Country (2017-2022)

7.2 Europe Ankylosing Spondylitis Treatment Drug Market Size by Type (2017-2022)

7.3 Europe Ankylosing Spondylitis Treatment Drug Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Ankylosing Spondylitis Treatment Drug by Region (2017-2022)

8.2 Middle East & Africa Ankylosing Spondylitis Treatment Drug Market Size by Type (2017-2022)

8.3 Middle East & Africa Ankylosing Spondylitis Treatment Drug Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Ankylosing Spondylitis Treatment Drug Market Forecast

10.1 Global Ankylosing Spondylitis Treatment Drug Forecast by Regions (2023-2028)

10.1.1 Global Ankylosing Spondylitis Treatment Drug Forecast by Regions (2023-2028)

10.1.2 Americas Ankylosing Spondylitis Treatment Drug Forecast

10.1.3 APAC Ankylosing Spondylitis Treatment Drug Forecast

10.1.4 Europe Ankylosing Spondylitis Treatment Drug Forecast

10.1.5 Middle East & Africa Ankylosing Spondylitis Treatment Drug Forecast

10.2 Americas Ankylosing Spondylitis Treatment Drug Forecast by Country (2023-2028)

10.2.1 United States Ankylosing Spondylitis Treatment Drug Market Forecast

10.2.2 Canada Ankylosing Spondylitis Treatment Drug Market Forecast

10.2.3 Mexico Ankylosing Spondylitis Treatment Drug Market Forecast

10.2.4 Brazil Ankylosing Spondylitis Treatment Drug Market Forecast

10.3 APAC Ankylosing Spondylitis Treatment Drug Forecast by Region (2023-2028)

10.3.1 China Ankylosing Spondylitis Treatment Drug Market Forecast

10.3.2 Japan Ankylosing Spondylitis Treatment Drug Market Forecast

10.3.3 Korea Ankylosing Spondylitis Treatment Drug Market Forecast

10.3.4 Southeast Asia Ankylosing Spondylitis Treatment Drug Market Forecast

10.3.5 India Ankylosing Spondylitis Treatment Drug Market Forecast

10.3.6 Australia Ankylosing Spondylitis Treatment Drug Market Forecast

10.4 Europe Ankylosing Spondylitis Treatment Drug Forecast by Country (2023-2028)

10.4.1 Germany Ankylosing Spondylitis Treatment Drug Market Forecast

10.4.2 France Ankylosing Spondylitis Treatment Drug Market Forecast

10.4.3 UK Ankylosing Spondylitis Treatment Drug Market Forecast

10.4.4 Italy Ankylosing Spondylitis Treatment Drug Market Forecast

10.4.5 Russia Ankylosing Spondylitis Treatment Drug Market Forecast

10.5 Middle East & Africa Ankylosing Spondylitis Treatment Drug Forecast by Region (2023-2028)

10.5.1 Egypt Ankylosing Spondylitis Treatment Drug Market Forecast

10.5.2 South Africa Ankylosing Spondylitis Treatment Drug Market Forecast

10.5.3 Israel Ankylosing Spondylitis Treatment Drug Market Forecast

10.5.4 Turkey Ankylosing Spondylitis Treatment Drug Market Forecast

10.5.5 GCC Countries Ankylosing Spondylitis Treatment Drug Market Forecast

10.6 Global Ankylosing Spondylitis Treatment Drug Forecast by Type (2023-2028)

10.7 Global Ankylosing Spondylitis Treatment Drug Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Abbott

11.1.1 Abbott Company Information

11.1.2 Abbott Ankylosing Spondylitis Treatment Drug Product Offered

11.1.3 Abbott Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Abbott Main Business Overview

11.1.5 Abbott Latest Developments

11.2 Merck

11.2.1 Merck Company Information

11.2.2 Merck Ankylosing Spondylitis Treatment Drug Product Offered

11.2.3 Merck Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Merck Main Business Overview

11.2.5 Merck Latest Developments

11.3 Eisai

11.3.1 Eisai Company Information

11.3.2 Eisai Ankylosing Spondylitis Treatment Drug Product Offered

11.3.3 Eisai Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Eisai Main Business Overview

11.3.5 Eisai Latest Developments

11.4 Novartis

11.4.1 Novartis Company Information

11.4.2 Novartis Ankylosing Spondylitis Treatment Drug Product Offered

11.4.3 Novartis Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Novartis Main Business Overview

11.4.5 Novartis Latest Developments

11.5 Pfizer

11.5.1 Pfizer Company Information

11.5.2 Pfizer Ankylosing Spondylitis Treatment Drug Product Offered

11.5.3 Pfizer Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Pfizer Main Business Overview

11.5.5 Pfizer Latest Developments

11.6 Johson & Johson

11.6.1 Johson & Johson Company Information

11.6.2 Johson & Johson Ankylosing Spondylitis Treatment Drug Product Offered

11.6.3 Johson & Johson Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Johson & Johson Main Business Overview

11.6.5 Johson & Johson Latest Developments

11.7 Abbive

11.7.1 Abbive Company Information

11.7.2 Abbive Ankylosing Spondylitis Treatment Drug Product Offered

11.7.3 Abbive Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Abbive Main Business Overview

11.7.5 Abbive Latest Developments

11.8 UCB

11.8.1 UCB Company Information

11.8.2 UCB Ankylosing Spondylitis Treatment Drug Product Offered

11.8.3 UCB Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 UCB Main Business Overview

11.8.5 UCB Latest Developments

11.9 Amgen

11.9.1 Amgen Company Information

11.9.2 Amgen Ankylosing Spondylitis Treatment Drug Product Offered

11.9.3 Amgen Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Amgen Main Business Overview

11.9.5 Amgen Latest Developments

11.10 Takeda

11.10.1 Takeda Company Information

11.10.2 Takeda Ankylosing Spondylitis Treatment Drug Product Offered

11.10.3 Takeda Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Takeda Main Business Overview

11.10.5 Takeda Latest Developments

11.11 Mitsubishi Tanabe

11.11.1 Mitsubishi Tanabe Company Information

11.11.2 Mitsubishi Tanabe Ankylosing Spondylitis Treatment Drug Product Offered

11.11.3 Mitsubishi Tanabe Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Mitsubishi Tanabe Main Business Overview

11.11.5 Mitsubishi Tanabe Latest Developments

11.12 Hisun Pharm

11.12.1 Hisun Pharm Company Information

11.12.2 Hisun Pharm Ankylosing Spondylitis Treatment Drug Product Offered

11.12.3 Hisun Pharm Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Hisun Pharm Main Business Overview

11.12.5 Hisun Pharm Latest Developments

11.13 Guojian Pharmaceutical

11.13.1 Guojian Pharmaceutical Company Information

11.13.2 Guojian Pharmaceutical Ankylosing Spondylitis Treatment Drug Product Offered

11.13.3 Guojian Pharmaceutical Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Guojian Pharmaceutical Main Business Overview

11.13.5 Guojian Pharmaceutical Latest Developments

11.14 Bio-Thera Solutions

11.14.1 Bio-Thera Solutions Company Information

11.14.2 Bio-Thera Solutions Ankylosing Spondylitis Treatment Drug Product Offered

11.14.3 Bio-Thera Solutions Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Bio-Thera Solutions Main Business Overview

11.14.5 Bio-Thera Solutions Latest Developments

11.15 Maibo Pharma

11.15.1 Maibo Pharma Company Information

11.15.2 Maibo Pharma Ankylosing Spondylitis Treatment Drug Product Offered

11.15.3 Maibo Pharma Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Maibo Pharma Main Business Overview

11.15.5 Maibo Pharma Latest Developments

11.16 Celgen Pharm

11.16.1 Celgen Pharm Company Information

11.16.2 Celgen Pharm Ankylosing Spondylitis Treatment Drug Product Offered

11.16.3 Celgen Pharm Ankylosing Spondylitis Treatment Drug Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Celgen Pharm Main Business Overview

11.16.5 Celgen Pharm Latest Developments

12 Research Findings and Conclusion

Table 1. Ankylosing Spondylitis Treatment Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Non-steroidal Anti-inflammatory Drugs

Table 3. Major Players of Inhibitor

Table 4. Ankylosing Spondylitis Treatment Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Ankylosing Spondylitis Treatment Drug Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Ankylosing Spondylitis Treatment Drug Market Size Market Share by Type (2017-2022)

Table 7. Ankylosing Spondylitis Treatment Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Ankylosing Spondylitis Treatment Drug Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Ankylosing Spondylitis Treatment Drug Market Size Market Share by Application (2017-2022)

Table 10. Global Ankylosing Spondylitis Treatment Drug Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Ankylosing Spondylitis Treatment Drug Revenue Market Share by Player (2020-2022)

Table 12. Ankylosing Spondylitis Treatment Drug Key Players Head office and Products Offered

Table 13. Ankylosing Spondylitis Treatment Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Ankylosing Spondylitis Treatment Drug Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Ankylosing Spondylitis Treatment Drug Market Size Market Share by Regions (2017-2022)

Table 18. Americas Ankylosing Spondylitis Treatment Drug Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Ankylosing Spondylitis Treatment Drug Market Size Market Share by Country (2017-2022)

Table 20. Americas Ankylosing Spondylitis Treatment Drug Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Ankylosing Spondylitis Treatment Drug Market Size Market Share by Type (2017-2022)

Table 22. Americas Ankylosing Spondylitis Treatment Drug Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Ankylosing Spondylitis Treatment Drug Market Size Market Share by Application (2017-2022)

Table 24. APAC Ankylosing Spondylitis Treatment Drug Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Ankylosing Spondylitis Treatment Drug Market Size Market Share by Region (2017-2022)

Table 26. APAC Ankylosing Spondylitis Treatment Drug Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Ankylosing Spondylitis Treatment Drug Market Size Market Share by Type (2017-2022)

Table 28. APAC Ankylosing Spondylitis Treatment Drug Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Ankylosing Spondylitis Treatment Drug Market Size Market Share by Application (2017-2022)

Table 30. Europe Ankylosing Spondylitis Treatment Drug Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Ankylosing Spondylitis Treatment Drug Market Size Market Share by Country (2017-2022)

Table 32. Europe Ankylosing Spondylitis Treatment Drug Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Ankylosing Spondylitis Treatment Drug Market Size Market Share by Type (2017-2022)

Table 34. Europe Ankylosing Spondylitis Treatment Drug Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Ankylosing Spondylitis Treatment Drug Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Ankylosing Spondylitis Treatment Drug Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Ankylosing Spondylitis Treatment Drug Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Ankylosing Spondylitis Treatment Drug Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Ankylosing Spondylitis Treatment Drug Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Ankylosing Spondylitis Treatment Drug Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Ankylosing Spondylitis Treatment Drug Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Ankylosing Spondylitis Treatment Drug

Table 43. Key Market Challenges & Risks of Ankylosing Spondylitis Treatment Drug

Table 44. Key Industry Trends of Ankylosing Spondylitis Treatment Drug

Table 45. Global Ankylosing Spondylitis Treatment Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Ankylosing Spondylitis Treatment Drug Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Ankylosing Spondylitis Treatment Drug Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Ankylosing Spondylitis Treatment Drug Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Ankylosing Spondylitis Treatment Drug Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Ankylosing Spondylitis Treatment Drug Market Size Market Share Forecast by Application (2023-2028)

Table 51. Abbott Details, Company Type, Ankylosing Spondylitis Treatment Drug Area Served and Its Competitors

Table 52. Abbott Ankylosing Spondylitis Treatment Drug Product Offered

Table 53. Abbott Ankylosing Spondylitis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Abbott Main Business

Table 55. Abbott Latest Developments

Table 56. Merck Details, Company Type, Ankylosing Spondylitis Treatment Drug Area Served and Its Competitors

Table 57. Merck Ankylosing Spondylitis Treatment Drug Product Offered

Table 58. Merck Main Business

Table 59. Merck Ankylosing Spondylitis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Merck Latest Developments

Table 61. Eisai Details, Company Type, Ankylosing Spondylitis Treatment Drug Area Served and Its Competitors

Table 62. Eisai Ankylosing Spondylitis Treatment Drug Product Offered

Table 63. Eisai Main Business

Table 64. Eisai Ankylosing Spondylitis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Eisai Latest Developments

Table 66. Novartis Details, Company Type, Ankylosing Spondylitis Treatment Drug Area Served and Its Competitors

Table 67. Novartis Ankylosing Spondylitis Treatment Drug Product Offered

Table 68. Novartis Main Business

Table 69. Novartis Ankylosing Spondylitis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Novartis Latest Developments

Table 71. Pfizer Details, Company Type, Ankylosing Spondylitis Treatment Drug Area Served and Its Competitors

Table 72. Pfizer Ankylosing Spondylitis Treatment Drug Product Offered

Table 73. Pfizer Main Business

Table 74. Pfizer Ankylosing Spondylitis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Pfizer Latest Developments

Table 76. Johson & Johson Details, Company Type, Ankylosing Spondylitis Treatment Drug Area Served and Its Competitors

Table 77. Johson & Johson Ankylosing Spondylitis Treatment Drug Product Offered

Table 78. Johson & Johson Main Business

Table 79. Johson & Johson Ankylosing Spondylitis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Johson & Johson Latest Developments

Table 81. Abbive Details, Company Type, Ankylosing Spondylitis Treatment Drug Area Served and Its Competitors

Table 82. Abbive Ankylosing Spondylitis Treatment Drug Product Offered

Table 83. Abbive Main Business

Table 84. Abbive Ankylosing Spondylitis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Abbive Latest Developments

Table 86. UCB Details, Company Type, Ankylosing Spondylitis Treatment Drug Area Served and Its Competitors

Table 87. UCB Ankylosing Spondylitis Treatment Drug Product Offered

Table 88. UCB Main Business

Table 89. UCB Ankylosing Spondylitis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. UCB Latest Developments

Table 91. Amgen Details, Company Type, Ankylosing Spondylitis Treatment Drug Area Served and Its Competitors

Table 92. Amgen Ankylosing Spondylitis Treatment Drug Product Offered

Table 93. Amgen Main Business

Table 94. Amgen Ankylosing Spondylitis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Amgen Latest Developments

Table 96. Takeda Details, Company Type, Ankylosing Spondylitis Treatment Drug Area Served and Its Competitors

Table 97. Takeda Ankylosing Spondylitis Treatment Drug Product Offered

Table 98. Takeda Main Business

Table 99. Takeda Ankylosing Spondylitis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Takeda Latest Developments

Table 101. Mitsubishi Tanabe Details, Company Type, Ankylosing Spondylitis Treatment Drug Area Served and Its Competitors

Table 102. Mitsubishi Tanabe Ankylosing Spondylitis Treatment Drug Product Offered

Table 103. Mitsubishi Tanabe Ankylosing Spondylitis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. Mitsubishi Tanabe Main Business

Table 105. Mitsubishi Tanabe Latest Developments

Table 106. Hisun Pharm Details, Company Type, Ankylosing Spondylitis Treatment Drug Area Served and Its Competitors

Table 107. Hisun Pharm Ankylosing Spondylitis Treatment Drug Product Offered

Table 108. Hisun Pharm Main Business

Table 109. Hisun Pharm Ankylosing Spondylitis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. Hisun Pharm Latest Developments

Table 111. Guojian Pharmaceutical Details, Company Type, Ankylosing Spondylitis Treatment Drug Area Served and Its Competitors

Table 112. Guojian Pharmaceutical Ankylosing Spondylitis Treatment Drug Product Offered

Table 113. Guojian Pharmaceutical Main Business

Table 114. Guojian Pharmaceutical Ankylosing Spondylitis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 115. Guojian Pharmaceutical Latest Developments

Table 116. Bio-Thera Solutions Details, Company Type, Ankylosing Spondylitis Treatment Drug Area Served and Its Competitors

Table 117. Bio-Thera Solutions Ankylosing Spondylitis Treatment Drug Product Offered

Table 118. Bio-Thera Solutions Main Business

Table 119. Bio-Thera Solutions Ankylosing Spondylitis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 120. Bio-Thera Solutions Latest Developments

Table 121. Maibo Pharma Details, Company Type, Ankylosing Spondylitis Treatment Drug Area Served and Its Competitors

Table 122. Maibo Pharma Ankylosing Spondylitis Treatment Drug Product Offered

Table 123. Maibo Pharma Main Business

Table 124. Maibo Pharma Ankylosing Spondylitis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 125. Maibo Pharma Latest Developments

Table 126. Celgen Pharm Details, Company Type, Ankylosing Spondylitis Treatment Drug Area Served and Its Competitors

Table 127. Celgen Pharm Ankylosing Spondylitis Treatment Drug Product Offered

Table 128. Celgen Pharm Main Business

Table 129. Celgen Pharm Ankylosing Spondylitis Treatment Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 130. Celgen Pharm Latest Developments

List of Figures

Figure 1. Ankylosing Spondylitis Treatment Drug Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Ankylosing Spondylitis Treatment Drug Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Ankylosing Spondylitis Treatment Drug Market Size Market Share by Type in 2021

Figure 7. Ankylosing Spondylitis Treatment Drug in Hospital Pharmacy

Figure 8. Global Ankylosing Spondylitis Treatment Drug Market: Hospital Pharmacy (2017-2022) & ($ Millions)

Figure 9. Ankylosing Spondylitis Treatment Drug in Retail Pharmacy

Figure 10. Global Ankylosing Spondylitis Treatment Drug Market: Retail Pharmacy (2017-2022) & ($ Millions)

Figure 11. Ankylosing Spondylitis Treatment Drug in Online Pharmacy

Figure 12. Global Ankylosing Spondylitis Treatment Drug Market: Online Pharmacy (2017-2022) & ($ Millions)

Figure 13. Ankylosing Spondylitis Treatment Drug in Other

Figure 14. Global Ankylosing Spondylitis Treatment Drug Market: Other (2017-2022) & ($ Millions)

Figure 15. Global Ankylosing Spondylitis Treatment Drug Market Size Market Share by Application in 2021

Figure 16. Global Ankylosing Spondylitis Treatment Drug Revenue Market Share by Player in 2021

Figure 17. Global Ankylosing Spondylitis Treatment Drug Market Size Market Share by Regions (2017-2022)

Figure 18. Americas Ankylosing Spondylitis Treatment Drug Market Size 2017-2022 ($ Millions)

Figure 19. APAC Ankylosing Spondylitis Treatment Drug Market Size 2017-2022 ($ Millions)

Figure 20. Europe Ankylosing Spondylitis Treatment Drug Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa Ankylosing Spondylitis Treatment Drug Market Size 2017-2022 ($ Millions)

Figure 22. Americas Ankylosing Spondylitis Treatment Drug Value Market Share by Country in 2021

Figure 23. Americas Ankylosing Spondylitis Treatment Drug Consumption Market Share by Type in 2021

Figure 24. Americas Ankylosing Spondylitis Treatment Drug Market Size Market Share by Application in 2021

Figure 25. United States Ankylosing Spondylitis Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada Ankylosing Spondylitis Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico Ankylosing Spondylitis Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil Ankylosing Spondylitis Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC Ankylosing Spondylitis Treatment Drug Market Size Market Share by Region in 2021

Figure 30. APAC Ankylosing Spondylitis Treatment Drug Market Size Market Share by Application in 2021

Figure 31. China Ankylosing Spondylitis Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan Ankylosing Spondylitis Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea Ankylosing Spondylitis Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia Ankylosing Spondylitis Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 35. India Ankylosing Spondylitis Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia Ankylosing Spondylitis Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe Ankylosing Spondylitis Treatment Drug Market Size Market Share by Country in 2021

Figure 38. Europe Ankylosing Spondylitis Treatment Drug Market Size Market Share by Type in 2021

Figure 39. Europe Ankylosing Spondylitis Treatment Drug Market Size Market Share by Application in 2021

Figure 40. Germany Ankylosing Spondylitis Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 41. France Ankylosing Spondylitis Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK Ankylosing Spondylitis Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy Ankylosing Spondylitis Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia Ankylosing Spondylitis Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa Ankylosing Spondylitis Treatment Drug Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa Ankylosing Spondylitis Treatment Drug Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa Ankylosing Spondylitis Treatment Drug Market Size Market Share by Application in 2021

Figure 48. Egypt Ankylosing Spondylitis Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa Ankylosing Spondylitis Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel Ankylosing Spondylitis Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey Ankylosing Spondylitis Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country Ankylosing Spondylitis Treatment Drug Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas Ankylosing Spondylitis Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 54. APAC Ankylosing Spondylitis Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 55. Europe Ankylosing Spondylitis Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa Ankylosing Spondylitis Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 57. United States Ankylosing Spondylitis Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 58. Canada Ankylosing Spondylitis Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 59. Mexico Ankylosing Spondylitis Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 60. Brazil Ankylosing Spondylitis Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 61. China Ankylosing Spondylitis Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 62. Japan Ankylosing Spondylitis Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 63. Korea Ankylosing Spondylitis Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia Ankylosing Spondylitis Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 65. India Ankylosing Spondylitis Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 66. Australia Ankylosing Spondylitis Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 67. Germany Ankylosing Spondylitis Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 68. France Ankylosing Spondylitis Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 69. UK Ankylosing Spondylitis Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 70. Italy Ankylosing Spondylitis Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 71. Russia Ankylosing Spondylitis Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 72. Spain Ankylosing Spondylitis Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 73. Egypt Ankylosing Spondylitis Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 74. South Africa Ankylosing Spondylitis Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 75. Israel Ankylosing Spondylitis Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 76. Turkey Ankylosing Spondylitis Treatment Drug Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries Ankylosing Spondylitis Treatment Drug Market Size 2023-2028 ($ Millions)